Annual CFO
-$43.10 M
+$15.46 M+26.39%
December 1, 2024
Summary
- As of March 13, 2025, DSGN annual cash flow from operations is -$43.10 million, with the most recent change of +$15.46 million (+26.39%) on December 1, 2024.
- During the last 3 years, DSGN annual CFO has fallen by -$13.73 million (-46.73%).
- DSGN annual CFO is now -30910.79% below its all-time high of -$139.00 thousand, reached on December 31, 2019.
Performance
DSGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$9.86 M
-$314.00 K-3.29%
December 1, 2024
Summary
- As of March 13, 2025, DSGN quarterly cash flow from operations is -$9.86 million, with the most recent change of -$314.00 thousand (-3.29%) on December 1, 2024.
- Over the past year, DSGN quarterly CFO has dropped by -$314.00 thousand (-3.29%).
- DSGN quarterly CFO is now -654.40% below its all-time high of -$1.31 million, reached on June 30, 2020.
Performance
DSGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$43.10 M
+$2.94 M+6.38%
December 1, 2024
Summary
- As of March 13, 2025, DSGN TTM cash flow from operations is -$43.10 million, with the most recent change of +$2.94 million (+6.38%) on December 1, 2024.
- Over the past year, DSGN TTM CFO has increased by +$2.94 million (+6.38%).
- DSGN TTM CFO is now -1521.10% below its all-time high of -$2.66 million, reached on March 31, 2020.
Performance
DSGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
DSGN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.4% | -3.3% | +6.4% |
| 3 y3 years | -46.7% | -3.3% | +6.4% |
| 5 y5 years | -10000.0% | -3.3% | +6.4% |
DSGN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.7% | +26.4% | -6.9% | +43.4% | -46.7% | +29.2% |
| 5 y | 5-year | <-9999.0% | +26.4% | -654.4% | +43.4% | -1521.1% | +29.2% |
| alltime | all time | <-9999.0% | +26.4% | -654.4% | +43.4% | -1521.1% | +29.2% |
Design Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$43.10 M(-26.4%) | -$9.86 M(+3.3%) | -$43.10 M(-6.4%) |
| Sep 2024 | - | -$9.55 M(-15.2%) | -$46.04 M(-9.8%) |
| Jun 2024 | - | -$11.26 M(-9.5%) | -$51.03 M(-4.7%) |
| Mar 2024 | - | -$12.44 M(-2.8%) | -$53.58 M(-8.5%) |
| Dec 2023 | -$58.56 M(+14.1%) | -$12.80 M(-11.9%) | -$58.56 M(-3.8%) |
| Sep 2023 | - | -$14.53 M(+5.3%) | -$60.85 M(+1.1%) |
| Jun 2023 | - | -$13.80 M(-20.8%) | -$60.22 M(+5.8%) |
| Mar 2023 | - | -$17.42 M(+15.5%) | -$56.91 M(+10.9%) |
| Dec 2022 | -$51.32 M | -$15.09 M(+8.6%) | -$51.32 M(+12.9%) |
| Sep 2022 | - | -$13.90 M(+32.4%) | -$45.45 M(+14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$10.50 M(-11.2%) | -$39.72 M(+5.9%) |
| Mar 2022 | - | -$11.83 M(+28.2%) | -$37.51 M(+27.7%) |
| Dec 2021 | -$29.38 M(+238.9%) | -$9.23 M(+13.0%) | -$29.38 M(+27.8%) |
| Sep 2021 | - | -$8.16 M(-1.5%) | -$22.99 M(+37.8%) |
| Jun 2021 | - | -$8.29 M(+124.2%) | -$16.69 M(+71.9%) |
| Mar 2021 | - | -$3.70 M(+30.0%) | -$9.71 M(+12.0%) |
| Dec 2020 | -$8.67 M(+6136.7%) | -$2.84 M(+53.0%) | -$8.67 M(+48.8%) |
| Sep 2020 | - | -$1.86 M(+42.2%) | -$5.83 M(+46.9%) |
| Jun 2020 | - | -$1.31 M(-50.8%) | -$3.97 M(+49.2%) |
| Mar 2020 | - | -$2.66 M | -$2.66 M |
| Dec 2019 | -$139.00 K | - | - |
FAQ
- What is Design Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Design Therapeutics?
- What is Design Therapeutics annual CFO year-on-year change?
- What is Design Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Design Therapeutics?
- What is Design Therapeutics quarterly CFO year-on-year change?
- What is Design Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Design Therapeutics?
- What is Design Therapeutics TTM CFO year-on-year change?
What is Design Therapeutics annual cash flow from operations?
The current annual CFO of DSGN is -$43.10 M
What is the all time high annual CFO for Design Therapeutics?
Design Therapeutics all-time high annual cash flow from operations is -$139.00 K
What is Design Therapeutics annual CFO year-on-year change?
Over the past year, DSGN annual cash flow from operations has changed by +$15.46 M (+26.39%)
What is Design Therapeutics quarterly cash flow from operations?
The current quarterly CFO of DSGN is -$9.86 M
What is the all time high quarterly CFO for Design Therapeutics?
Design Therapeutics all-time high quarterly cash flow from operations is -$1.31 M
What is Design Therapeutics quarterly CFO year-on-year change?
Over the past year, DSGN quarterly cash flow from operations has changed by -$314.00 K (-3.29%)
What is Design Therapeutics TTM cash flow from operations?
The current TTM CFO of DSGN is -$43.10 M
What is the all time high TTM CFO for Design Therapeutics?
Design Therapeutics all-time high TTM cash flow from operations is -$2.66 M
What is Design Therapeutics TTM CFO year-on-year change?
Over the past year, DSGN TTM cash flow from operations has changed by +$2.94 M (+6.38%)